TS-091

· Taisho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TS-091, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects [Phase 1]

See pricing